SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more
Market Cap & Net Worth: SANUWAVE Health, Inc. Common Stock (SNWV)
SANUWAVE Health, Inc. Common Stock (OTCQB:SNWV) has a market capitalization of $263.03 Million ($263.03 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #16450 globally and #6334 in its home market, demonstrating a -18.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SANUWAVE Health, Inc. Common Stock's stock price $30.67 by its total outstanding shares 8576164 (8.58 Million).
SANUWAVE Health, Inc. Common Stock Market Cap History: 2015 to 2025
SANUWAVE Health, Inc. Common Stock's market capitalization history from 2015 to 2025. Data shows change from $209.04 Million to $263.03 Million (-4.73% CAGR).
Index Memberships
SANUWAVE Health, Inc. Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #443 of 976 |
Weight: SANUWAVE Health, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
SANUWAVE Health, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SANUWAVE Health, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.52x
SANUWAVE Health, Inc. Common Stock's market cap is 5.52 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $209.04 Million | $965.50K | -$4.81 Million | 216.51x | N/A |
| 2016 | $562.49 Million | $1.38 Million | -$6.44 Million | 408.77x | N/A |
| 2017 | $778.29 Million | $738.53K | -$5.54 Million | 1053.84x | N/A |
| 2018 | $739.69 Million | $1.85 Million | -$11.63 Million | 399.82x | N/A |
| 2019 | $514.57 Million | $1.03 Million | -$12.27 Million | 500.20x | N/A |
| 2020 | $594.97 Million | $4.06 Million | -$30.94 Million | 146.64x | N/A |
| 2021 | $546.73 Million | $13.01 Million | -$27.26 Million | 42.02x | N/A |
| 2022 | $73.33 Million | $16.74 Million | -$10.29 Million | 4.38x | N/A |
| 2023 | $41.81 Million | $20.40 Million | -$25.81 Million | 2.05x | N/A |
| 2024 | $180.10 Million | $32.63 Million | -$31.37 Million | 5.52x | N/A |
Competitor Companies of SNWV by Market Capitalization
Companies near SANUWAVE Health, Inc. Common Stock in the global market cap rankings as of March 18, 2026.
Key companies related to SANUWAVE Health, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
SANUWAVE Health, Inc. Common Stock Historical Marketcap From 2015 to 2025
Between 2015 and today, SANUWAVE Health, Inc. Common Stock's market cap moved from $209.04 Million to $ 263.03 Million, with a yearly change of -4.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $263.03 Million | +46.05% |
| 2024 | $180.10 Million | +330.77% |
| 2023 | $41.81 Million | -42.98% |
| 2022 | $73.33 Million | -86.59% |
| 2021 | $546.73 Million | -8.11% |
| 2020 | $594.97 Million | +15.62% |
| 2019 | $514.57 Million | -30.43% |
| 2018 | $739.69 Million | -4.96% |
| 2017 | $778.29 Million | +38.36% |
| 2016 | $562.49 Million | +169.08% |
| 2015 | $209.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SANUWAVE Health, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $263.03 Million USD |
| MoneyControl | $263.03 Million USD |
| MarketWatch | $263.03 Million USD |
| marketcap.company | $263.03 Million USD |
| Reuters | $263.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.